Farther Finance Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8K Buy
1,517
+1,248
+464% +$6.57K ﹤0.01% 4565
2026
Q1
$1.12K Sell
269
-966
-78% -$4.65K ﹤0.01% 5077
2025
Q4
$5.94K Sell
1,235
-377
-23% -$1.82K ﹤0.01% 4208
2025
Q3
$8.16K Buy
1,612
+1,559
+2,942% +$6.89K ﹤0.01% 3535
2025
Q2
$214 Buy
+53
New +$172 ﹤0.01% 4195
2025
Q1
Sell
-53
Closed -$225 4281
2024
Q4
$225 Hold
53
﹤0.01% 3633
2024
Q3
$156 Sell
53
-1
-2% -$3 ﹤0.01% 3703
2024
Q2
$180 Hold
54
﹤0.01% 3513
2024
Q1
$169 Sell
54
-3
-5% -$9 ﹤0.01% 3302
2023
Q4
$201 Buy
+57
New +$164 ﹤0.01% 3224

Other funds holding SRTA

Farther Finance Advisors's SRTA Position: Q2 2026 in Review

Farther Finance Advisors increased its Strata Critical Medical Inc (SRTA) stake by 464% in Q2 2026, buying an estimated $6.57K and bringing the position to 1,517 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4565.

Farther Finance Advisors first reported a position in SRTA in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.16K in Q3 2025. 12 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Farther Finance Advisors held 1,517 shares of Strata Critical Medical Inc worth $8K as of Q2 2026.
  • Farther Finance Advisors bought 1,248 Strata Critical Medical Inc shares in Q2 2026, an estimated $6.57K.
  • Strata Critical Medical Inc made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4565 holding.
  • Farther Finance Advisors first reported a position in Strata Critical Medical Inc in Q4 2023 and has held it in 10 quarters since.
  • Farther Finance Advisors's Strata Critical Medical Inc position peaked at $8.16K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.